Who we are
The Ketamine Assisted Therapy Association of Canada (KATA) is a not-for-profit organization that furthers the development of ketamine assisted therapy (KAT) through activities that support professionals, practitioners and physicians. KATA provides opportunities for facilities offering KAT to refine their services and deliver treatment that is transparent and respects patients values and culture.
Sign up For Canadian Ketamine Updates
Why are we here
Ketamine-assisted therapy (KAT) can be defined as the combination of the administration of ketamine with an additional non-pharmacological component to treatment such as psychotherapy. Ketamine has been used as an adjunct to psychotherapy since the 1970s and is becoming more widely accepted as a safe and effective tool to add to therapy for several mental health conditions. KATA provides a platform and community for meaningful collaboration, dialogue and initiatives focused on improving outcomes for those receiving or in need of KAT.
Donate To Kata Canada
Help us raise funds to broaden our reach in making Ketamine Assisted Therapy in Canada safely accessible.
Latest News
Stay up to date on the latest news for ketamine regulatory requirements, practice recommendations, developments in ketamine research, and updates and information affecting the delivery of ketamine assisted therapy in Canada.
Ketamine’s History as a Useful Medicine and a Therapeutic Tool for Mental Health Conditions
Ketamine is an N-methyl-d-aspartate receptor antagonist and glutamatergic modulator.
Read More
Canada’s Ketamine Association Releases Recommendations for Practice Standards
Guideline for Safe and Accessible Treatment
Read More
Ketamine Practice Survey Live
Until October 21st KATA Canada is collecting responses in the form of a practice survey to better understand how ketamine is being delivered for mental health conditions in Canada currently.
Read More